EUVIMEDEUVIMED entdecken
Crossref

Exploring zingerone 2-thiohydantoins as anticancer agents against breast adenocarcinoma: Cytotoxicity, HSA and DNA binding, molecular docking and ADMET prediction

Petar Stanić, Ana Rilak-Simović, Katarina Virijević, Jovana Muškinja, Nevena Jeremić, Goran Janjić, Biljana Šmit

Acta Chimica Slovenica · 20.06.2026 · 73 · 371-384

DOI: 10.17344/acsi.2025.9631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Chimica Slovenica, online erschienen am 20.06.2026. Verfasst von Petar Stanić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Information Technologies, University of Kragujevac, Serbia. Hauptthemen laut MEDLINE: Antineoplastic Agents, Molecular Docking Simulation, DNA, Breast Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates a series of zingerone 2-thiohydantoins for anticancer activity towards human breast adenocarcinoma and explores possible mechanisms of anticancer action. Cytotoxicity was tested on highly invasive triple negative breast cancer MDA-MB-231 cells and healthy MRC-5 cells. The most active compound 2e exerted a significant cytotoxic effect on breast cancer cells, while exhibiting no measurable toxicity on healthy cells. Fluorescence measurements of interactions with human serum albumin, combined with molecular docking, showed strong binding and transport capabilities, suggesting good bioavailability. Fluorescence and hydrodynamic measurements with DNA displayed lower binding affinity, suggesting that protein targets are responsible for anticancer action. Thorough molecular docking screening on 36 possible breast adenocarcinoma protein targets was performed and results suggest competitive inhibition of DNA methyltransferase 1 as the mechanism of anticancer action. ADMET analysis predicted favorable physicochemical and pharmacokinetic properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsMolecular Docking SimulationDNABreast NeoplasmsAdenocarcinomaHumansFemaleMDA-MB-231 CellsCell Line, Tumor

Substanzen

Antineoplastic AgentsDNA

Autor:innen und Institutionen

  • Institute for Information Technologies, University of Kragujevac, Serbia.
  • Center of Excellence for Redox Balance Research in Cardiovascular and Metabolic Disorders, Serbia; Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Serbia; Federal State Autonomous Educatio…
  • Institute of Chemistry, Technology and Metallurgy, University of Belgrade, Serbia.

Zitieren

APA

Stanić, P., Rilak-Simović, A., Virijević, K., Muškinja, J., Jeremić, N., Janjić, G., & Šmit, B. (2026). Exploring zingerone 2-thiohydantoins as anticancer agents against breast adenocarcinoma: Cytotoxicity, HSA and DNA binding, molecular docking and ADMET prediction. Acta Chimica Slovenica, 73, 371-384. https://doi.org/10.17344/acsi.2025.9631

Vancouver

Stanić P, Rilak-Simović A, Virijević K, Muškinja J, Jeremić N, Janjić G, et al. Exploring zingerone 2-thiohydantoins as anticancer agents against breast adenocarcinoma: Cytotoxicity, HSA and DNA binding, molecular docking and ADMET prediction. Acta Chimica Slovenica. 2026;73:371-384. doi:10.17344/acsi.2025.9631

BibTeX
@article{Stani2026,
  author = {Stanić, Petar and Rilak-Simović, Ana and Virijević, Katarina and Muškinja, Jovana and Jeremić, Nevena and Janjić, Goran and Šmit, Biljana},
  title = {Exploring zingerone 2-thiohydantoins as anticancer agents against breast adenocarcinoma: Cytotoxicity, HSA and DNA binding, molecular docking and ADMET prediction},
  journal = {Acta Chimica Slovenica},
  year = {2026},
  volume = {73},
  pages = {371--384},
  doi = {10.17344/acsi.2025.9631}
}
Kostenlos starten →